SUMMARY
- Integris Health has appointed Probir Das as its CEO with his tenure commencing on November 1, 2024.
- Das had been serving as the Chairman and Managing Director of Terumo Asia Pacific since 2019.
- Das has an extensive background of over 30 years within the global medtech sector.
Integris Health has appointed Probir Das as its Chief Executive Officer, with his tenure commencing on November 1, 2024. Das will be headquartered in New Delhi, India, and has an extensive background of over 30 years within the global medtech or healthtech sector.
In his previous role, Das had been serving as the Chairman and Managing Director of Terumo Asia Pacific since 2019.
Das’s leadership capabilities and successful history at Terumo in India and Southeast Asia have been highlighted, with Avnish Mehra, Vice Chairman at Everstone Capital, stating that his extensive experience and seniority position him as an ideal candidate for Integris.
While discussing the expansion of the company’s market presence and delivering advanced medical technologies, Das said, “I look forward to expanding Integris’ market presence by delivering cutting-edge medical technologies to patients worldwide.”
Gurmit Chugh, Co-founder of Integris, said, “He is a leader who has created a culture of collaboration and accountability by empowering teams to exceed their goals. His commitment to sustainable growth is very encouraging.”
Moreover, Das’s emphasis on the significance of collaboration in the pursuit of sustainable development and the transformation of healthcare delivery was highlighted.
